Clinical Distinguished Investigator
Clinical Distinguished Investigator supports clinically active research leaders undertaking patient-relevant clinical and translational projects to strengthen Danish research and advance human health.
Browse similar grants
Funder: Novo Nordisk Foundation
Due Dates: November 18, 2026 (Call opens) | January 20, 2027, 2:00pm Copenhagen time (Call closes) | Beginning of June 2027 (Results) | November 2027 (Recurring call)
Funding Amounts: Up to DKK 11 million per grant over five years; up to two grants
Summary: Supports established, clinically active research leaders undertaking patient-relevant clinical and translational research in Denmark.
Key Information: Applicants must retain clinical responsibilities throughout the grant, with an expected 20–50% clinical commitment.
Description
The Novo Nordisk Foundation’s Clinical Distinguished Investigator programme supports clinically active research leaders at professor level who have demonstrated the ability to lead research at the highest international level. It aims to strengthen Danish clinical and translational research through ambitious, clinically relevant five-year projects while maintaining the investigator’s connection to clinical work.
The research scope includes patient- and disease-related research, disease mechanisms, treatment methods, disease trajectories, diagnostic methods, epidemiology, public health, family medicine and biomedicine. Supported approaches can include intervention studies, register-based research, proof-of-concept studies, pilot projects, initial clinical trials and clinical testing. These examples do not limit the eligible research fields; the overarching goal is relevance to patients and human health.
